{"id":"NCT02218697","sponsor":"GlaxoSmithKline","briefTitle":"Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine 2014/2015 Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10-01","primaryCompletion":"2015-01-14","completion":"2015-05-04","firstPosted":"2014-08-18","resultsPosted":"2017-03-09","lastUpdate":"2018-04-03"},"enrollment":357,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Influsplit™ Tetra (Fluarix™ Tetra)","otherNames":["D-QIV","GSK2321138A"]},{"type":"BIOLOGICAL","name":"Pneumovax™ 23","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo (Saline)","otherNames":[]}],"arms":[{"label":"Co-Ad Group","type":"EXPERIMENTAL"},{"label":"Control Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to investigate the immunogenicity and safety when GSK Biologicals' influenza vaccine Influsplit™ Tetra (Fluarix™ Tetra) is co-administered with Merck \\& Co. Inc.'s pneumococcal vaccine (Pneumovax™23/Pneumovax) in adults 50 years of age and older at risk for complications from influenza and pneumococcal infections.","primaryOutcome":{"measure":"Humoral Immune Response in Terms of Haemagglutination Inhibition (HI) Antibodies Titers Against the 4 Vaccine Strains.","timeFrame":"At Day 28 post Influsplit™ Tetra vaccination","effectByArm":[{"arm":"Control Group","deltaMin":253.2,"sd":null},{"arm":"Co-Ad Group","deltaMin":235.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":20},"locations":{"siteCount":6,"countries":["Belgium","France"]},"refs":{"pmids":["28987445"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":179},"commonTop":["Pain","Fatigue","Myalgia","Headache","Arthralgia"]}}